# cbdMD, Inc.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/cbdMD, Inc.).

## Overview

cbdMD, Inc. is a U.S.-based consumer products company that develops and sells hemp-derived wellness products under brands including cbdMD, Paw CBD, ATRx Labs, and Herbal Oasis. Its portfolio spans CBD tinctures, gummies, topicals, capsules, sleep and focus aids, functional mushroom products, and THC-infused beverages, sold through e-commerce, wholesale, and selected retail channels.

## Products & services

• CBD tinctures, gummies, topicals and capsules
• Sleep, focus and calming wellness products
• Paw CBD pet wellness products
• ATRx Labs functional mushroom and nootropic products
• Herbal Oasis THC-infused ready-to-drink beverages
• E-commerce, wholesale and retail distribution

- **CBD wellness products** (55%) — Broad-spectrum and full-spectrum hemp-derived CBD products for human use.
- **Pet wellness products** (10%) — CBD-based products sold under Paw CBD for pet health and wellness.
- **Functional mushroom and nootropic products** (10%) — ATRx Labs products focused on mushroom-based and cognitive wellness formulations.
- **THC beverages** (15%) — Herbal Oasis hemp-derived THC-infused ready-to-drink beverage products.
- **Wholesale and retail channel sales** (10%) — Sales through retail accounts, distributors, and other third-party channels.

- CBD tinctures, gummies, topicals and capsules
- Sleep, focus and calming wellness products
- Paw CBD pet wellness products
- ATRx Labs functional mushroom and nootropic products
- Herbal Oasis THC-infused ready-to-drink beverages
- E-commerce, wholesale and retail distribution

## Customers

cbdMD sells primarily to consumers buying directly online, as well as wholesale and retail partners that stock its branded hemp-derived products. Its customer base also includes pet owners, wellness-oriented shoppers, and channel partners such as specialty retailers, distributors, and beverage wholesalers.

- **Direct-to-consumer wellness shoppers** (primary) — Buy CBD and wellness products online or by phone for convenience and brand selection.
- **Wholesale retail accounts** (primary) — Retailers and specialty chains buy branded SKUs to sell through physical stores.
- **Distributors** (secondary) — Regional and category distributors buy products to expand market reach and placement.
- **Pet owners** (secondary) — Buy Paw CBD products for pet wellness and companion-animal use cases.
- **International consumers and partners** (emerging) — Buy through local wholesalers, legal partners, and e-commerce channels outside the U.S.

- Direct-to-consumer shoppers buying online or by phone
- Wholesale accounts seeking CBD and hemp-derived products
- Specialty retailers such as Sprouts and GNC
- Distributors supporting regional beverage and wellness rollouts
- Pet owners purchasing Paw CBD products
- International consumers reached through local partners and Amazon UK

## Geography

cbdMD is headquartered in Charlotte, North Carolina and operates primarily in the United States. The company also sells into the United Kingdom through e-commerce and is pursuing additional international wholesale markets, especially in Central and South America.

- Headquartered and operated from Charlotte, North Carolina
- Primary sales and distribution market is the United States
- UK e-commerce sales support international consumer reach
- Central and South America are targeted through local partners
- State-by-state U.S. distribution matters for hemp and THC products
- Local legal and regulatory partners are used in foreign markets

## Strategy

cbdMD is focused on expanding its revenue channels across direct-to-consumer, wholesale, and retail distribution while broadening its brand portfolio. It is also building out newer growth platforms such as Herbal Oasis beverages and extending international sales through local partners and e-commerce.

- **Broaden distribution for Oasis and other brands** (short-term) — More retail and distributor placements increase product availability and brand scale.
- **Improve direct-to-consumer marketing efficiency** (short-term) — Online sales depend on cost-effective customer acquisition and repeat purchasing.
- **Build a multi-brand wellness platform** (medium-term) — Multiple brands can broaden the addressable market and reduce reliance on one product line.
- **Expand internationally through compliant channels** (medium-term) — Foreign markets can add growth, but require local regulatory navigation.

- Expand wholesale and retail account penetration
- Grow Oasis beverage distribution across more states
- Strengthen direct-to-consumer marketing efficiency
- Develop additional brands and cross-sell across the portfolio
- Pursue international expansion through local partners
- Use education and brand awareness to support repeat purchases

## Risks

The business is exposed to regulatory scrutiny around hemp-derived cannabinoids, especially advertising and product claims, and to state-by-state packaging or labeling requirements. It also depends on efficient customer acquisition and continued acceptance of newer products, while wholesale and international expansion add execution and compliance complexity.

- **Regulatory enforcement on CBD and THC claims** [high] — The company markets hemp-derived wellness products that can attract FTC/FDA scrutiny.
- **State-level packaging and labeling changes** [medium] — Different jurisdictions may require reworks and reformulation of packaging materials.
- **Customer acquisition efficiency** [high] — Online sales rely on paid marketing and may become more expensive over time.
- **International regulatory complexity** [medium] — Foreign sales require local legal counsel and market-specific approvals.
- **Going concern / continued losses** [high] — A history of operating losses can constrain investment and strategic flexibility.

- FTC and FDA scrutiny of CBD advertising and health claims
- State-level hemp and THC rules can change packaging and labeling costs
- Direct-to-consumer growth depends on efficient customer acquisition
- Wholesale demand can be affected by regulatory uncertainty
- International expansion adds legal and compliance complexity
- Losses and listing compliance create financial and market risk

## Accounting

Revenue is recognized when control transfers, generally upon shipment, and net sales are reduced for returns, discounts, allowances, and promotional incentives. Inventory valuation, product returns, and write-downs are important estimates, while advertising, lease, and intangible asset costs can materially affect reported results because the company relies on brand-building and distribution assets.

- **Revenue recognition and returns reserve** — Affects reported net sales and comparability across periods
- **Inventory valuation** — Can materially affect cost of sales and gross margin
- **Advertising and marketing expense** — Creates period-to-period volatility in operating expenses
- **Intangible assets and amortization** — Can affect operating income and equity values
- **Lease accounting** — Affects operating expenses and balance sheet obligations

- Revenue recognized on shipment when title and risk transfer
- Net sales reduced by returns, discounts and customer allowances
- 60-day money-back guarantee affects return reserves
- Inventory write-downs and refurbishing costs can move gross margin
- Lease and warehouse costs affect operating expense timing
- Intangible asset amortization and impairment may affect earnings

---

*Last updated: 2026-04-29T05:12:09.803290+00:00*